Apart from iNOS signaling, some of the well-known key angiogenesis and metastatic transcription factors described in in vivo study, including vascular endothelial growth factor A (VEGFA), have been demonstrated as potential therapeutic targets for cancer [15, 16]. The gene discussed is NOS2; the disease is cancer.